We're now investing out of NFX Fund IV. Like you, we're operators and entrepreneurs. We believe the world of technology is at a turning point. Here are the key details on Fund IV, including who we work with, and what themes we're tracking: https://lnkd.in/e6a2mA9G
NFX
Venture Capital and Private Equity Principals
San Francisco, California 30,776 followers
NFX is a venture firm exclusively focused on pre-seed & seed stage startups.
About us
NFX is a venture firm exclusively focused on pre-seed & seed stage startups.
- Website
-
http://www.nfx.com
External link for NFX
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 11-50 employees
- Headquarters
- San Francisco, California
- Type
- Partnership
- Founded
- 2017
- Specialties
- Network Effects, Product Design, Growth, Positioning & Branding, Strategy, and Code of Confidentiality
Locations
-
Primary
Get directions
32 Page St
San Francisco, California 94102, US
-
Get directions
Herzlia, Israel, IL
Employees at NFX
Updates
-
NFX reposted this
💰 Cyclana Bio (ex. Cycle Therapeutics) has announced its £5 million pre-seed round co-led by NFX and Eka Ventures, with participation from Cocoa 🍫, Wilbe, and angel investors. The UK-based company is targeting the extracellular matrix - the mesh of proteins and molecules that surrounds cells and provides structural support to tissue - to reverse scarring and develop new treatments for endometriosis. 🔬 💬 "Our mission at Cyclana is not just to close the gender health gap but propel women to the forefront of drug discovery. We are redefining how therapies are developed, starting with the basic science, by studying disease at the level where it truly emerges: the tissue itself." Cyclana Bio (ex. Cycle Therapeutics) Co-founder & CEO Dr. Léa Wenger 👉 Full story: https://lnkd.in/gNnXCr3j #femtech #womenshealth #womenshealthinnovation #health #healthcare #biotech #research #endometriosis #pelvicpain #investment #investor #vc #venturecapital #startup Kevin Chalut Tom Wyatt Amy Lock
-
-
We're excited to have backed EvenUp from the very beginning. Congratulations to the team on their $150M Series E! Here's what we saw in them on day 0: https://lnkd.in/eYmE4NBv
-
NFX reposted this
We started EvenUp to fix a broken system that left millions behind, not to build a $2B AI company. Every year, millions of injury victims face a system stacked against them. Cases drag on, fair settlements slip away, and the attorneys fighting for them often lack the tools or resources to make things right. We believed AI could change that, even when few thought it was possible. Fast forward a few years, and today I’m proud to share that EvenUp has raised $150 million in our Series E, led by Bessemer Venture Partners, bringing our valuation to over $2 billion. We’ve now supported 200,000+ cases, helped secure $10B+ in settlements, and become the AI backbone for thousands of personal injury firms powering 10,000+ cases every week. We’re not just creating powerful AI products - we’re helping attorneys fight for every dollar their clients deserve and giving millions a fairer shot at justice. - To our 500+ Upsters: thank you for pouring your heart into this mission. - To our customers: thank you for your trust and partnership. - To our investors, especially Bessemer, and with gratitude to REV (the venture arm of RELX / LexisNexis), B Capital, Bain Capital Ventures (BCV), Lightspeed, Premji Invest - US, SignalFire, NFX and DCM Ventures thank you for seeing what’s possible. Raymond, Saam, and I couldn’t be prouder of what we’ve built, and why we began. The wildest part? We’re only 1% in. The best is yet to come as we continue to EvenUp the playing field. 💥 💡 The Fortune article in the comments dives deeper into our journey — from being turned down by YC three times to building a company changing how justice gets done.
-
Fundraising runs on a calendar most founders don’t see. There are hot windows where investors are focused, decisions move quickly, and momentum compounds. And there are slow seasons where even great companies struggle to break through. Understanding that rhythm — and timing your raise accordingly — can change your outcome. Omri Amirav-Drory on The Seasons of Fundraising ⬇️
-
Without bio, the AI utopia doesn’t exist. Yes, AI will create enormous financial value. But the “big picture” goals — curing disease, extending life, halting climate change — depend on applying AI to science. Today in the newsletter: Omri Amirav-Drory on why both tech investors and bio founders are needed to deliver on AI's promise. https://lnkd.in/dMJriNhR
-
Spots are filling up in our AI + Bio event. We'll cover where founders are finding traction, what investors look for, and more. 📍 NFX HQ, San Francisco 📅 Monday, Sept 22 ⏰ 6–9 PM PT Register here: https://luma.com/kntoa5kw
-
AI is everywhere in bio right now. But how much is real and how much is hype? Next Monday (9/22), we’re hosting a live event at NFX HQ to cut through the noise. What's happening? We're gathering founders and investors to discuss: 🔹 Founder Panel → How builders are applying AI in techbio today, where they're finding traction, what challenges are unique to the industry... 🔹 Investor Panel → What signals separate durable companies from hype cycles? How is capital being allocated in the space? Details: 📍 NFX HQ, San Francisco 📅 Monday, Sept 22 ⏰ 6–9 PM PT 👉 Register here: https://luma.com/kntoa5kw
-
For decades, cybersecurity meant defending the OS perimeter. But today, the real threats live at the application layer: plugins, extensions, AI models, and code packages. The battleground has shifted. This shift creates a new windows for startups. We're excited about the multiple tech windows opening in cyber – today and in the future. Gigi Levy-Weiss describes the big ideas and how top teams are gaining fast traction in this space: https://lnkd.in/dM_FvvSn
-
We're excited to invest in F2, an AI platform for private financial market investors. F2 was spun out of Arc, one of our portfolio companies. They're out of stealth today, after 1yr of fine tuning to become enterprise-grade. Congratulations to the team! Here's what we saw in them from day 0: https://lnkd.in/ettkra2v